Cell Signaling Technology

Phospho-p130 Cas (Tyr165) Antibody

#4015 · $362

100
Citing papers
14.5k
Combined citations
Supplier page Find this product

Research areas

Cancer, Hypoxia, and Metabolism12Cancer Cells and Metastasis11Epigenetics and DNA Methylation9Glioma Diagnosis and Treatment9MicroRNA in disease regulation8Immune cells in cancer7Angiogenesis and VEGF in Cancer6Immune Cell Function and Interaction6

Papers citing this product

1
Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis
Journal of Clinical Investigation·2008·822 cit.·DOI
2
NOTCH Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts  
Stem Cells·2009·643 cit.·DOI
3
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
Journal of Clinical Investigation·2018·598 cit.·DOI
4
JNK-Induced MCP-1 Production in Spinal Cord Astrocytes Contributes to Central Sensitization and Neuropathic Pain
Journal of Neuroscience·2009·564 cit.·DOI
5
CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer
Stem Cells·2009·450 cit.·DOI
6
The transcription factor HIF-1α plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis
Genes & Development·2007·422 cit.·DOI
7
IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity
Nature·2018·402 cit.·DOI
8
Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
The Journal of Experimental Medicine·2012·402 cit.·DOI
9
Iron overloaded polarizes macrophage to proinflammation phenotype through <scp>ROS</scp>/acetyl‐p53 pathway
Cancer Medicine·2018·332 cit.·DOI
10
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
Laboratory Investigation·2008·331 cit.·DOI